Gaetano Guglielmino

CIK: 0002047624

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TMCI

TREACE MEDICAL CONCEPTS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

TMCI
TREACE MEDICAL CONCEPTS, INC.
Jan 22, 2026
Award(A)
Direct
150K shares-
TMCI
TREACE MEDICAL CONCEPTS, INC.
Dec 1, 2025
Tax Payment(F)
Direct
20.1K shares-
TMCI
TREACE MEDICAL CONCEPTS, INC.
Dec 1, 2025
Tax Payment(F)
Direct
2K shares-
TMCI
TREACE MEDICAL CONCEPTS, INC.
Dec 1, 2024
Award(A)
Direct
330K shares-
TMCI
TREACE MEDICAL CONCEPTS, INC.
Dec 1, 2024
Award(A)
Direct
33K shares-

		Type	Shares	Price		Ownership
Jan 22, 2026	TMCI TREACE MEDICAL CONCEPTS, INC.	Award(A)	150,000	-	$0	Direct
Dec 1, 2025	TMCI TREACE MEDICAL CONCEPTS, INC.	Tax Payment(F)	20,090	-	-	Direct
Dec 1, 2025	TMCI TREACE MEDICAL CONCEPTS, INC.	Tax Payment(F)	2,009	-	-	Direct
Dec 1, 2024	TMCI TREACE MEDICAL CONCEPTS, INC.	Award(A)	330,000	-	$0	Direct
Dec 1, 2024	TMCI TREACE MEDICAL CONCEPTS, INC.	Award(A)	33,000	-	$0	Direct

1-5 of 5 transactions

About Guglielmino Gaetano

Guglielmino Gaetano (SEC CIK 0002047624) files insider reports with the SEC as Chief Commercial Officer of TREACE MEDICAL CONCEPTS, INC. (TMCI).

Signal8 holds 4 ownership filings by Guglielmino Gaetano (1 Form 3, 3 Form 4), filed between Dec 5, 2024 and Jan 23, 2026. Those filings report 5 transactions, from Dec 1, 2024 to Jan 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Guglielmino Gaetano's filings is in PONTE VEDRA, FL.

Recent filings by Guglielmino Gaetano

Jan 22, 2026: Grant or award of TMCI shares (Form 4, code A).
Dec 1, 2025: Tax withholdings of TMCI shares (2 lines, Form 4, code F).
Dec 1, 2024: Grants or awards of TMCI shares (2 lines, Form 4, code A).

Other insiders filing for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Scanlan Sean F., Chief Innovation Officer
Elder Scot Michael, Chief Legl & Comp Off, CorpSec
Treace John T., Chief Executive Officer
Hair Mark, Chief Financial Officer
BAKEWELL JOHN K, Director
Kiernan Jane E, Director

How to read Form 4 transaction codes